Skip to main content
SpringerLink
Log in

Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers

  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

There have been few studies to date of clinical photodynamic therapy (PDT) with tetra(m-hydroxyphenyl)chlorin (mTHPC). This paper describes the results of the authors' experience with this second-generation photosensitizer, used in the treatment of 40 early cancers of the oesophagus and the bronchi. Surface illumination of the tumour was performed, in most cases, 4 days after intravenous injection of 0.15 mg kg−1 of mTHPC, using 652 nm or 514 nm continuous wave laser light. Endoscopic follow-up with biopsies and brushings was possible for 35 tumours: 27 (77%) showed no recurrence after disease-free follow-ups that ranged from 3 to 38 months. Major complications, all of which were after red light illumination, included one bronchial stenosis, one oesophagotracheal fistula and two probable occult perforations of the oesophagus. Photodynamic therapy with green light renders such perforations of the oesophageal wall essentially impossible at the applied conditions, and appears not to reduce the efficacy of the treatment. Skin photosensitization, which was never observed later than the first week after injection, occurred in 12 patients. Hence, PDT with mTHPC is a safe and effective treatment for early carcinomas of the oesophagus and the tracheobronchial tree.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Savary M, Monnier Ph, Pasche R et al. Multiple primary malignancies.Adv Otorhinolaryngol 1991,46:165–75

    PubMed  Google Scholar 

  2. Shons AR, McQuarrie DG. Multiple primary epidermoid carcinomas of the upper aerodigestive tract.Arch Surg 1985,120:1007–9

    PubMed  Google Scholar 

  3. Gluckman JL, Crissman JD. Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract.Laryngoscope 1983,93:71–4

    PubMed  Google Scholar 

  4. Cohn AM, Peppard SB. Multiple primary malignant tumors of the head and neck.Am J Otolaryngol 1980,1:411–7

    PubMed  Google Scholar 

  5. Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection.Chest 1992,102:1319–22

    PubMed  Google Scholar 

  6. Sibille A, Lambert R, Souquet JC et al. Long-term survival after photodynamic therapy for esophageal cancer.Gastroenterology 1995,108:337–44

    PubMed  Google Scholar 

  7. Kato H, Horai T, Furuse K et al. Photodynamic therapy for cancers: a clinical trial of porfimer sodium in Japan.Jpn J Cancer Res 1993,84:1209–14

    PubMed  Google Scholar 

  8. Monnier Ph, Savary M, Fontolliet Ch et al. Photodection and photodynamic therapy of “early” squamous cell carcinomas of the pharynx, esophagus and tracheobronchial tree.Lasers Med Sci 1990,5:149–69

    Google Scholar 

  9. Monnier Ph, Fontolliet Ch, Wagnières G et al. Further appraisal of PDI and PDT of early squamous cell carcinomas of the pharynx, esophagus and bronchi. In: Spinelli P, Dal Fante M, Marchesini R (eds)Photodynamic Therapy and Biomedical Lasers, Vol 1011. Excerpta Medica, International Congress Series, 1992:7–14

  10. Berenbaum MC, Bonnett R, Scourides PA. In vivo biological activity of the components of haematoporphyrin derivative.Br J Cancer 1982,45:571–81

    PubMed  Google Scholar 

  11. Wagnières G, Braichotte D, Folli S et al. Measurement of the Photofrin II absolute fluorescence quantum yield in tissue.Photochem Photobiol 1994,59:S81

    Google Scholar 

  12. Dougherty TJ, Cooper MT, Mang TS. Cutaneous phototoxic occurrences in patients receiving Photofrin.Lasers Surg Med 1990,10:485–8

    PubMed  Google Scholar 

  13. Berenbaum MC, Bonnett R, Chevretton EB et al. Selectivity of meso-tetra-(hydroxyphenyl)porphyrins and chlorins and Photofrin in causing photodamage in tumor, skin, muscle and bladder. The concept of costbenefit in analysing the results.Lasers Med Sci 1993,8:235–43

    Google Scholar 

  14. Ma L, Moan J, Berg K. Evaluation of a new photosensitizer, meso-tetra-hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers.Int J Cancer 1994,57:883–8

    PubMed  Google Scholar 

  15. Van Geel IPJ, Oppelaar H, Oussoren YG et al. Photosensitizing efficacy of mTHPC-PDT compared to Photofrin-PDT in the RIF1 mouse tumour and normal skin.Int J Cancer 1995,60:388–94

    PubMed  Google Scholar 

  16. Savary JF, Monnier Ph, Wagnières G et al. Preliminary clinical studies of photodynamic therapy with mesotetrahydroxyphenyl chlorin (m-THPC) as a photosensitizing agent for the treatment of early pharyngeal, esophageal and bronchial carcinomas.SPIE Proceedings Series, Bellingham WA, USA 1993,2078:330–40

    Google Scholar 

  17. Dilkes MG, DeJode ML, Gardiner Q et al. Treatment of head and neck cancer with photodynamic therapy: results after one year.J Laryngol Otol 1995,109:1072–6

    PubMed  Google Scholar 

  18. Ris HB, Altermatt HJ, Nachbur B et al. Intraoperative photodynamic therapy with m-tetra-hydroxyphenylchlorin for chest malignancies.Lasers Surg Med 1996,18:39–45

    PubMed  Google Scholar 

  19. Bogomoletz WV, Molas G, Gayet B, Potet F. Superficial squamous cell carcinoma of the esophagus. A report of 76 cases and review of the literature.Am J Surg Pathol 1989,13:535–46

    PubMed  Google Scholar 

  20. Woolner LB, Fontana RS, Cortese DA et al. Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period.Mayo Clin Proc 1984,59:453–66

    PubMed  Google Scholar 

  21. Kitamura K, Ikebe M, Morita M et al. The evaluation of submucosal carcinoma of the esophagus as a more advanced carcinoma.Hepato-Gastroenterol 1993,40:236–9

    Google Scholar 

  22. Monnier Ph, Fontolliet Ch, Ollyo JB. Endoscopic findings of 100 early-stage esophageal cancers.Diagn Therap Endosc 1994,1:83–92

    Google Scholar 

  23. Van den Bergh H, Mizeret J, Theumann JF et al. Light distributors for photodynamic therapy.SPIE Proceedings Series, Bellingham WA, USA 1996,2631:173–98

    Google Scholar 

  24. Wagnières G, Monnier Ph, Savary M et al. Photodynamic therapy of early cancer in the upper aerodigestive tract and bronchi: instrumentation and clinical results.Proc Soc Photo-Opt Instr Eng 1990,IS6:249–71

    Google Scholar 

  25. Braichotte DR, Savary JF, Monnier Ph, van den Bergh HE. Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy.Lasers Surg Med, in press

  26. McCaughan Jr JS, Hawley PC, Bethel BH, Walker J. Photodynamic therapy of endobronchial malignancies.Cancer 1988,62:691–701

    PubMed  Google Scholar 

  27. Balchum OJ, Doiron DR, Huth GC. Photoradiation therapy of endobronchial lung cancers employing the photodynamic action of hematoporphyrin derivative.Lasers Surg Med 1984,4:13–30

    PubMed  Google Scholar 

  28. McCaughan Jr JS, Nims TA, Guy JT et al. Photodynamic therapy for esophageal tumors.Arch Surg 1989,124:74–80

    PubMed  Google Scholar 

  29. Marcon NE. Photodynamic therapy and cancer of the esophagus.Semin Oncol 1994,21:S20–3

    Google Scholar 

  30. Sutedja T, Baas P, Stewart F, Van Zandwijk N. A pilot study of photodynamic therapy in patients with inoperable non-small cell lung cancer.Eur J Cancer 1992,28A:1370–3

    PubMed  Google Scholar 

  31. Cortese DA, Kinsey JH. Endoscopic management of lung cancer with hematoporphyrin derivative phototherapy.Mayo Clin Proc 1982,57:543–7

    PubMed  Google Scholar 

  32. Lam S. Photodynamic therapy in lung cancer.Semin Oncol 1994,21:S15–9

    Google Scholar 

  33. Bown SG. Photodynamic therapy in gastroenterology. Current status and future prospects.Endoscopy 1993,25:S683–6

    PubMed  Google Scholar 

  34. Edell ES, Cortese DA. Photodynamic therapy. Its use in the management of bronchogenic carcinoma.Clin Chest Med 1995,16:455–63

    PubMed  Google Scholar 

  35. Tian ME, Qui SL, Ji Q. Preliminary results of hematoporphyrin derivative-laser treatment for 13 cases of early esophageal carcinoma.Adv Exp Med Biol 1985,193:21–5

    PubMed  Google Scholar 

  36. Patrice T, Foultier MT, Yactayo S et al. Endoscopic photodynamic therapy with hematoporphyrin derivative for primary treatment of gastrointestinal neoplasms in inoperable patients.Dig Dis Sci 1990,35:545–52

    PubMed  Google Scholar 

  37. Marijnissen JPA, Baas P, Beek JF et al. Pilot study on light dosimetry for endobronchial photodynamic therapy.Photochem Photobiol 1993,58:92–9

    PubMed  Google Scholar 

  38. Wiersema MJ, Wiersema LM. High-resolution 25-megahertz ultrasonography of the gastrointestinal wall: histologic correlates.Gastrointest Endosc 1993,39:499–504

    PubMed  Google Scholar 

  39. Braichotte DR, Wagnières GA, Bays R et al. Clinical pharmacokinetic studies of Photofrin by fluorescence spectroscopy in the oral cavity, the esophagus, and the bronchi.Cancer 1995,75:2768–78

    PubMed  Google Scholar 

  40. Wagnières G, personal communication

  41. Hayata Y, Kato H, Konaka C et al. Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer.Chest 1984,86:169–77

    PubMed  Google Scholar 

  42. Lam S. Photodynamic therapy of lung cancer.Thorax 1993,48:469

    PubMed  Google Scholar 

  43. Kato H, Kawate N, Konoshita K et al. Photodynamic therapy of early stage lung cancer.Ciba Found Symp 1989,146:183–7

    PubMed  Google Scholar 

  44. Wagnières G, Braichotte D, Châtelain A et al. Photodetection of early cancer in the upper aerodigestive tract and the bronchi using Photofrin II and colorectal adenocarcinoma with fluoresceinated monoclonal antibodies.SPIE Proceedings Series, Bellingham WA, USA 1991,1525:212–8

    Google Scholar 

  45. Thomas RJ, Abbot M, Bhathal PS et al. High-dose photoirradiation of esophageal cancer.Ann Surg 1987,206:193–9

    PubMed  Google Scholar 

  46. Andrejevic S, Savary JF, Monnier Ph et al. Measurements by fluorescence microscopy of the time dependent meso-tetra-hydroxyphenylchlorin distribution in healthy tissues and chemically-induced “early” squamous cell carcinoma of the Syrian Hamster cheek pouch.J Photochem Photobiol (in press)

  47. Braichotte D, Savary JF, Glanzmann T et al. Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl) chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths.Int J Cancer 1995,63:198–204

    PubMed  Google Scholar 

  48. Tralau CJ, Barr H, Sandeman DR et al. Aluminium sulfonated phthalocyanine distribution in rodent tumours of the colon, brain and pancreas.Photochem Photobiol 1987,46:777–881

    PubMed  Google Scholar 

  49. Barr H, Tralau CJ, Krasner N et al. Photodynamic therapy with phthalocyanine sensitisation in the normal rat colon.British J Cancer 1987,56:111–18

    Google Scholar 

  50. Barr H, Tralau CJ, Boulos PB et al. The contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury.Photochem Photobiol 1987,46:795–800

    PubMed  Google Scholar 

  51. Bays R, Wagnières G, Robert D et al. Clinical determination of tissue optical properties by endoscopic spatially resolved reflectometry.Appl Optics 1996,35:1756–66

    Google Scholar 

  52. Smith SG, Bedwell J, MacRobert AJ et al. Experimental studies to assess the potential of photodynamic therapy for the treatment of bronchial carcinomas.Thorax 1993,48:474–80

    PubMed  Google Scholar 

  53. Overholt BF, Panjehpour M, DeNovo RC, Petersen MG. Photodynamic therapy for esophageal cancer using a 180° windowed esophageal balloon.Lasers Med Surg 1994,14:27–33

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Head and Neck Surgery, CHUV Hospital, Lausanne, Switzerland

    P. Grosjean, J. -F. Savary & P. Monnier

  2. Institute of Environmental Engineering, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland

    G. Wagnières, J. Mizeret, A. Woodtli, J. -F. Theumann & H. Van Den Bergh

  3. Institute of Pathology, CHUV Hospital, Lausanne, Switzerland

    C. Fontolliet

Authors
  1. P. Grosjean
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. -F. Savary
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Wagnières
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Mizeret
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Woodtli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. -F. Theumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. Fontolliet
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. Van Den Bergh
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Monnier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grosjean, P., Savary, J.F., Wagnières, G. et al. Tetra(m-hydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers. Laser Med Sci 11, 227–235 (1996). https://doi.org/10.1007/BF02134913

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02134913

Key words

Search

Navigation